![Eric Karas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Karas
Corporate Officer/Principal bij
ARS Subsidiary, Inc.
Vermogen: 73 056 $ op 31-08-2026
Profiel
Eric Karas is currently Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. since 2022.
Formerly, Mr. Karas was Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. from 2018 to 2022.
Mr. Karas also served as Chief Commercial Officer at ARS Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2026 | 12.176 ( 0,01% ) | 73 056 $ | 31-08-2026 |
Actieve functies van Eric Karas
| Bedrijven | Functie | Begin |
|---|---|---|
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Corporate Officer/Principal | 01-04-2022 |
Eerdere bekende functies van Eric Karas
| Bedrijven | Functie | Einde |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2026 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01-03-2022 |
Opleiding van Eric Karas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Eli Broad College of Business
 Eli Broad College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
